Key result
An expert panel discussed the treatment of hypertension in the elderly, suggesting that new recommendations may be indicated based on recent data.
An expert panel convened to discuss new recommendations for the treatment of hypertension in the elderly based on recent data.
Answers are grounded in this paper and cite their sources.
May guide clinical discussions on elderly hypertension; leaves open need for randomized confirmation of new recommendations.
Following a hypertension symposium in San Francisco in September 2007, an expert panel was convened to discuss the treatment of hypertension in the elderly. Based on recent data, new recommendations may be indicated. The session was moderated by Marvin Moser, MD, Clinical Professor of Medicine at Yale University, New Haven, CT. Participants were William Cushman, MD, Professor of Preventive Medicine and Medicine at the University of Tennessee in Memphis, and Michael Ziegler, MD, Professor of Medicine, University of California at San Diego. The discussion was supported by Novartis Pharmaceuticals and Merck & Company, and each author received an honorarium from Novartis Pharmaceuticals and Merck & Company for time and effort spent participating in the discussion and reviewing the transcript for intellectual content before publication. The authors maintained full control of the discussion and the resulting content of this article.
No takes yet. Share an insight, caveat, or question.
Moser et al. (2008) conducted a review in Hypertension. Treatment of hypertension was evaluated. An expert panel discussed the treatment of hypertension in the elderly, suggesting that new recommendations may be indicated based on recent data.
Synapse has enriched 10 related papers. Consider them for comparative context: